Oscotec Inc.

Translating science into medicine
회원가입

회원가입

로그인
PRESS

NEWSROOM

Notice Press Releases Publications IR Materials
Home NEWSROOM Press Releases
T기본글꼴
✔ 사이트를 뷰어로 보기 검색 Write

  1. Profiles of Four New Stock-Billionaires

    Date2007-02-19 MediaMBN PipelineOscotec
    Read More

  2. Oscotec shares rebound on launch of US clinical trial

    Date2017-12-11 MediaKBR (; Korea Biomedical Review) PipelineSKI-G-801
    Read More

  3. Oscotec`s acute leukemia treatment wins orphan drug status from FDA

    Date2018-11-23 MediaKBR (; Korea Biomedical Review) PipelineSKI-G-801
    Read More

  4. Oscotec wins exception policy for continued R&D for new drugs

    Date2019-06-25 MediaKBR (; Korea Biomedical Review) PipelineOscotec
    Read More

  5. Yuhan to start phase-3 trial on lung cancer drug Lazertinib

    Date2019-12-12 MediaKBR (; Korea Biomedical Review) PipelineLazertinib
    Read More

  6. Oscotec and Beactica Therapeutics announce license and collaboration agreement to develop new cancer drug

    Date2021-03-02 MediaCISION PipelineOscotec
    Read More

  7. Abstract 2010 : SKI-G-801, an AXL kinase inhibitor, blocks metastasis and induces anti-tumor immune response in various syngeneic cancer models

    Date2019-07-01 MediaCANCER RESEARCH PipelineSKI-G-801
    Read More

  8. Genosco/Yuhan Announce Results from Phase 1/2 Study of YH25448, a 3rd-Generation EGFR-TKI, in Advanced NSCLC to be Presented at ASCO 2018

    Date2018-05-16 MediaBusinesswire PipelineLazertinib
    Read More

  9. "ASCO 2018: Genosco/Yuhan Announce Results from Phase 1/2 Study of Lazertinib (YH25448, GNS-1480), a 3rd-Generation EGFR-TKI, in Advanced NSCLC"

    Date2018-06-03 MediaBusinesswire PipelineLazertinib
    Read More

  10. Korea`s Yuhan Licenses out Lung Cancer Treatment to Janssen Biotech

    Date2018-11-05 MediaBusinessKorea PipelineLazertinib
    Read More

  11. Other news to note for March 2, 2021

    Date2021-03-02 MediaBioWorld PipelineOscotec
    Read More

  12. Janssen Announces Phase 1 Results for Bispecific Antibody Amivantamab in the treatment of Patients with Advanced Non-Small Cell Lung Cancer Harboring Exon 20 Insertion Mutations

    Date2020-05-18 MediaBioSpace PipelineLazertinib
    Read More
Board Pagination Prev 1 2 3 Next
/ 3
© k2s0o1d6e0s8i2g7n. ALL RIGHTS RESERVED.
서버에 요청 중입니다. 잠시만 기다려 주십시오...